转录因子FOXF2通过向MSI2促进胰腺癌的发展和进展
Bang-Hua Zhong1, Yu-Teng Ma1, Jian Sun1
1Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, P.R. China.
Oncology reports
|June 7, 2024
概括
叉头盒F2 (FOXF2) 通过增强细胞增殖,迁移和入侵,促进胰腺癌 (PC) 的进展. 它调节细胞循环和细胞亡,部分通过控制MSI2转录,为PC提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胰腺癌 (PC) 是一种高度致命的恶性瘤,分子驱动因素不明.
- 转录因子Forkhead Box F2 (FOXF2) 在PC病变发生过程中的特定作用尚未被阐明.
研究的目的:
- 调查FOXF2在胰腺癌发育和进展中的功能作用和潜在的分子机制.
主要方法:
- 在体外和体内研究使用PC细胞系和异种移植小鼠模型.
- 细胞循环分析,细胞灭绝试验 (流细胞计,霍希斯特染色),西式涂抹,光酶试验和染色体免疫沉 (ChIP).
主要成果:
- 过度表达FOXF2增强了PC细胞的增殖,迁移,入侵和瘤生长.
- FOXF2促进了细胞周期G1-S过渡,并上调相关蛋白质 (循环D1,CDK2,p-CDK2,p-RB).
- 沉默FOXF2增加了亡,调节了亲和抗亡蛋白 (Bad,Bax,切割caspase-3,Bcl-2,Bcl-xl),并抑制了瘤生长.
- FOXF2直接与MSI2促进体结合,增加其转录,从而驱动PC进展;MSI2沉默逆转了FOXF2的增殖效应.
结论:
- FOXF2是胰腺癌进展中的关键瘤原因子.
- 福克斯F2通过增强增殖,迁移,入侵和抑制亡,部分通过调节MSI2转录来促进PC.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
Epigenetic Regulation
31.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.0K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


